The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000
Abstract
Predictive and pre‐natal testing for Huntington's Disease (HD) has been available since 1987. Initially this was offered by linkage analysis, which was surpassed by the advent of the direct mutation test for HD in 1993. Direct mutation analysis provided an accurate test that not only enhanced predictive and pre‐natal testing, but also permitted the diagnostic testing of symptomatic individuals. The objective of this study was to investigate the uptake, utilization, and outcome of predictive, pre‐natal and diagnostic testing in Canada from 1987 to April 1, 2000. A retrospective design was used; all Canadian medical genetics centres and their affiliated laboratories offering genetic testing for HD were invited to participate. A total of 15 of 22 centres (68.2%), currently offering or ever having offered genetic testing for HD, responded, providing data on test results, demographics, and clinical history. A total of 1061 predictive tests, 15 pre‐natal tests, and 626 diagnostic tests were performed. The uptake for predictive testing was approximately 18% of the estimated at‐risk Canadian population, ranging from 12.5% in the Maritimes to 20.7% in British Columbia. There appears to have been a decline in the rate of testing in recent years. Of the predictive tests, 45.0% of individuals were found to have an increased risk, and a preponderance of females (60.2%) sought testing. A greater proportion of those at ≤ 25% risk sought predictive testing once direct CAG mutation analysis had become available (10.9% after mutation analysis vs 4.7% before mutation analysis, p = 0.0077). Very few pre‐natal tests were requested. Of the 15 pre‐natal tests, 12 had an increased risk, resulting in termination of pregnancy in all but one. Diagnostic testing identified 68.5% of individuals to be positive by mutation analysis, while 31.5% of those with HD‐like symptoms were not found to have the HD mutation. The positive diagnostic tests included 24.5% of individuals with no known prior family history of HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Cited by
Langbehn, D., Brinkman, R., Falush, D., Paulsen, J., Hayden, M., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 817
Self-citationTechnical report: ethical and policy issues in genetic testing and screening of children
Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.176 · Cited by 448
Implementation and utilization of genetic testing in personalized medicine
Scott, S., Abul-Husn, N., Owusu Obeng, A., Sanderson, S., & Gottesman, O. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s48887 · Cited by 106
Metadata
- Authors
- Creighton, S., Almqvist, E., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., Welch, J., Riddell, C., Lokkesmoe, R., Khalifa, M., MacKenzie, J., Sajoo, A., Farrell, S., Robert, F., Shugar, A., Summers, A., Meschino, W., Allingham‐Hawkins, D., Chiu, T., Hunter, A., Allanson, J., Hare, H., Schween, J., Collins, L., Sanders, S., Greenberg, C., Cardwell, S., Lemire, E., MacLeod, P., & Hayden, M.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2003-06
- Volume
- 63
- Issue
- 6
- Pages
- 462-475
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1938315359
- Cited by
- 167
- References
- 1
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. https://app.cochat.ai/papers/10.1034/j.1399-0004.2003.00093.x
- The paper
- Creighton, S., Almqvist, E., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., Welch, J., Riddell, C., Lokkesmoe, R., Khalifa, M., MacKenzie, J., Sajoo, A., Farrell, S., Robert, F., Shugar, A., Summers, A., Meschino, W., Allingham‐Hawkins, D., Chiu, T., . . . Hayden, M. (2003). Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clinical Genetics. https://doi.org/10.1034/j.1399-0004.2003.00093.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.